Inside the research
STERIS plc
STE Research profile · latest available data
Price overview
$208.93
▲ +0.16 (+0.1%)
| 52w hi | $266.36 |
|---|---|
| 52w lo | $198.79 |
| Vol | 447.10K |
| As of | 25 Sep 2026 |
The Verdict
Our score -0.07
| Short | -0.32 |
|---|---|
| Medium | +0.03 |
| Long | +0.25 |
computed 2026-09-27
Key fundamentals
STERIS plc
Healthcare · Medical Devices
| Market cap | $20.37B |
|---|---|
| Enterprise value | $21.95B |
| Trailing P/E | 25.51x |
| Forward P/E | 17.06x |
| EV / EBITDA | 13.38x |
| P / S (ttm) | 3.37x |
| Profit margin | 13.3% |
| Return on equity | 11.4% |
| Revenue growth | +7.3% |
| Earnings growth | +14.0% |
| Debt / equity | 28.31 |
Layer Breakdown
| Layer | Raw | Contribution |
|---|---|---|
| Fundamental | +0.27 | |
| Sector | +0.08 | |
| Technical | -0.21 | |
| Earnings | +0.00 | |
| Sentiment | +0.00 |
macro × 1.00 · 2026-09-27
Business overview
STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
Risk Metrics
| Beta vs SPX | 0.51 |
|---|---|
| Corr SPX | 0.34 |
| Annual vol | 24.1% |
| Annual ret | -3.4% |
| Sharpe | -0.14 |
| Max DD | -25.8% |
Window: 504 trading days (504 obs)
Analyst Coverage
| Mean PT | $279.29 |
|---|---|
| High / Low | $300.00 / $231.00 |
| Median | $291.00 |
| Analysts | 7 |
| Strong Buy | 2 | |
|---|---|---|
| Buy | 3 | |
| Hold | 2 | |
| Sell | 0 | |
| Strong Sell | 1 |
Recent rating actions
| 2025-08-08 | Morgan Stanley | → Overweight |
| 2025-07-22 | Keybanc | → Overweight |
| 2025-07-15 | Morgan Stanley | → Overweight |
| 2025-05-29 | Jefferies | → Hold |
| 2025-05-19 | Morgan Stanley | → Equal-Weight |
| 2025-05-16 | JMP Securities | → Market Outperform |
Material Events
| Date | Event | 8-K |
|---|---|---|
| 2026-08-06 | Shareholder Vote | read |
| 2026-08-05 | Earnings Release, Restructuring… | read |
| 2026-05-11 | Earnings Release, Exhibits | read |
| 2026-05-07 | Officer / Director Change, Reg FD Disclosure… | read |
| 2026-04-06 | Officer / Director Change | read |
| 2026-02-04 | Earnings Release, Exhibits | read |
| 2025-11-05 | Earnings Release, Exhibits | read |
| 2025-08-06 | Earnings Release, Officer / Director Change… | read |
| 2025-07-03 | Officer / Director Change | read |
| 2025-05-14 | Earnings Release, Exhibits | read |
| 2025-03-03 | Other Material Event | read |
| 2025-02-05 | Earnings Release, Exhibits | read |
Dividends
| Yield (TTM) | 0.30% |
|---|---|
| $ / share (TTM) | $0.63 |
| 5y CAGR | +2.8% |
Annual dividend per share
| 2021 | $1.66 |
|---|---|
| 2022 | $1.80 |
| 2023 | $1.98 |
| 2024 | $2.18 |
| 2025 | $1.77 |
| 2026 | $0.63 |
SEC Filings
The Long Run
FY 2019–2025 · 7 years
| Line | Latest | CAGR | Trend |
|---|---|---|---|
| Revenue | $4.54B | +37.2% | |
| Gross profit | $1.98B | +9.1% | |
| Operating income | $836.12M | +12.5% | |
| Net income | $107.03M | +10.7% | |
| Cash from ops | $1.15B | +18.1% |
Indices
Recent Sessions
| Date | Open | High | Low | Close | Vol |
|---|---|---|---|---|---|
| Sep 25 | $208.11 | $209.69 | $207.21 | $208.93 | 447.10K |
| Sep 24 | $210.05 | $211.45 | $208.57 | $208.77 | 524.40K |
| Sep 23 | $208.41 | $210.33 | $207.07 | $209.98 | 534.00K |
| Sep 22 | $208.98 | $209.12 | $205.21 | $208.79 | 624.60K |
| Sep 21 | $205.36 | $207.46 | $203.32 | $206.97 | 984.60K |
Understand the score. Research layers are inputs to a model, and the available data has limits.
Read the methodology →